CLOSE X
Rossari Biotech Ltd.
Issue Open Date 13-Jul-20  
Issue Closing Date 15-Jul-20  
Application Money 100  
Allotment Money  
Price Band () 423 - 425  
Minimum Bid Quantity. 35  
Issue Size (Shares) 11682020  
Market Lot 1  
Objective

The net proceeds of the Fresh Issue, i.e. Gross proceeds of the Fresh Issue less the Offer Expenses apportioned to our Company (“Net Proceeds”) are proposed to be utilised in the following manner:1. Repayment/prepayment of certain indebtedness availed by our Company (including accrued interest) 2. Funding working capital requirements and3. General corporate purposes.

Business Description

No Description found

Promoter's Holding
Total Share Capital   48400000  
Offered to Public    
Promoter's Holding (Pre-Issue)   100  
Promoter's Holding (Post-Issue)    
Address
Address :201 A - B
2nd Floor
Akruti Corporate Park
L. B. S. Marg
Next To Ge Gardens
Kanjurmarg (W)
City :Mumbai, State :Maharashtra Pincode :400078 Phone :022 61233800 Email : info@rossarimail.com Website : www.rossari.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
Axis Capital Ltd.
ICICI Securities Ltd
Promoters
Edward Walter Menezes
Sunil Srinivasan Chari
BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2013 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

 ©  Copyrights 2022, BNK Capital Group All Rights Reserved

Designed & Developed - Accord Fintech Pvt. Ltd.